Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam S Helms

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|November 14, 2023
Matrix architecture and mechanics regulate myofibril organization, costamere assembly, and contractility of engineered myocardial microtissuesSamuel J DePalma, Javiera Jillberto, Austin E Stis, et al.
JACC. Basic to Translational Science|October 4, 2023
An Unbiased Screen Identified the Hsp70-BAG3 Complex as a Regulator of Myosin-Binding Protein C3Andrea D Thompson, Marcus J Wagner, Juliani Rodriguez, et al.
JAMA|March 18, 2017
Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical TrialSara Saberi, Matthew Wheeler, Jennifer Bragg-Gresham, et al.
JCI Insight|December 27, 2019
Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathyAdam S Helms, Vi T Tang, Thomas S O'Leary, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 19, 2024
Matrix Architecture and Mechanics Regulate Myofibril Organization, Costamere Assembly, and Contractility in Engineered Myocardial MicrotissuesSamuel J DePalma, Javiera Jilberto, Austin E Stis, et al.
JAMA Cardiology|January 7, 2026
Social Determinants of Health and Clinical Outcomes in Hypertrophic CardiomyopathyNeha Hafeez, Brian L Claggett, Anjali T Owens, et al.
Circulation|May 7, 2020
Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular CardiomyopathyEric D Smith, Neal K Lakdawala, Nikolaos Papoutsidakis, et al.
European Heart Journal|March 26, 2021
Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathyNicholas A Marston, Larry Han, Iacopo Olivotto, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 30, 2021
Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretationAndrea D Thompson, Adam S Helms, Anamika Kannan, et al.
Nature Communications|October 26, 2021
Physiologic biomechanics enhance reproducible contractile development in a stem cell derived cardiac muscle platformYao-Chang Tsan, Samuel J DePalma, Yan-Ting Zhao, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|November 14, 2023
Matrix architecture and mechanics regulate myofibril organization, costamere assembly, and contractility of engineered myocardial microtissuesSamuel J DePalma, Javiera Jillberto, Austin E Stis, et al.
JACC. Basic to Translational Science|October 4, 2023
An Unbiased Screen Identified the Hsp70-BAG3 Complex as a Regulator of Myosin-Binding Protein C3Andrea D Thompson, Marcus J Wagner, Juliani Rodriguez, et al.
JAMA|March 18, 2017
Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical TrialSara Saberi, Matthew Wheeler, Jennifer Bragg-Gresham, et al.
JCI Insight|December 27, 2019
Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathyAdam S Helms, Vi T Tang, Thomas S O'Leary, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 19, 2024
Matrix Architecture and Mechanics Regulate Myofibril Organization, Costamere Assembly, and Contractility in Engineered Myocardial MicrotissuesSamuel J DePalma, Javiera Jilberto, Austin E Stis, et al.
JAMA Cardiology|January 7, 2026
Social Determinants of Health and Clinical Outcomes in Hypertrophic CardiomyopathyNeha Hafeez, Brian L Claggett, Anjali T Owens, et al.
Circulation|May 7, 2020
Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular CardiomyopathyEric D Smith, Neal K Lakdawala, Nikolaos Papoutsidakis, et al.
European Heart Journal|March 26, 2021
Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathyNicholas A Marston, Larry Han, Iacopo Olivotto, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 30, 2021
Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretationAndrea D Thompson, Adam S Helms, Anamika Kannan, et al.
Nature Communications|October 26, 2021
Physiologic biomechanics enhance reproducible contractile development in a stem cell derived cardiac muscle platformYao-Chang Tsan, Samuel J DePalma, Yan-Ting Zhao, et al.
Pageof 6